Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Gainsville Hematology Oncology Associates
Gainesville, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Graves-Gilbert Clinic
Bowling Green, Kentucky, United States
- Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
- Mercy Hospital
Portland, Maine, United States
- Consultants in Medical Oncology and Hematology
Drexel Hill, Pennsylvania, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 28 Feb 2009
- Completion
- 31 Dec 2009
- Last update posted
- 13 Nov 2012
- Registered enrollment
- 69
- Registry id
- NCT00193453
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.